curiouscat
Full Member (100+ posts)
157 Posts Gratitude: 19
|
Posted - 06/20/2006 : 07:37:28
|
In 2004, the Committee for the Safety of Medicines (CSM) in the UK issued a warning that risperidone and another atypical antipsychotic, olanzapine, should not be given to elderly patients with dementia, because of an increased risk of cerebrovascular adverse events including stroke.
A study in the June 2006 edition of the journal Pharmacotherapy has highlighted a possible link between risperdone and pituitary tumors. The study examined the FDA's Adverse Event Reporting System database and found 77 pituitary tumors associated with antipsychotics. Of these, risperidone was associated with 54 (70%). One co-author cautioned that "Our findings do not prove a causal relationship between antipsychotic medications and pituitary tumors" and "atypical antipsychotics are lifesaving medications for a lot of people. By no means are we advocating that people stop using them, especially risperidone". |
|